Scarlet

Lumafield, founded in 2019 in Cambridge, Massachusetts, specializes in developing industrial X-ray CT scanners and software that help engineers view the interior of manufactured parts and products in 3D.

Series C · $75M · 2025-03

Nervonik, founded in 2020 in Los Angeles, California, USA, develops implantable peripheral nerve stimulation devices that deliver personalized chronic pain treatment through electrical signals and real-time sensing.

Series B · $53M · 2026-05

Proprio, founded in 2016 and headquartered in Seattle, develops an AI-powered surgical platform. Its flagship product, Paradigm, has received FDA 510(k) clearance and is designed to improve surgical precision and efficiency.

Series B · $43M · 2023-08

BCI-Sonics, founded in 2025 in Shanghai, China, develops a next-generation AI ultrasound brain-computer interface platform integrating AI algorithms, transcranial focused ultrasound (tFUS-LIFU), and multimodal neural decoding technologies, targeting deep, non-invasive, personalized BCIs for medical and neuroscience applications.

Series A · $42M · 2026-09

Kossel Medtech is a Suzhou-based platform vascular-intervention device maker spanning peripheral intervention, coronary stents and balloons, cardiac electrophysiology and vascular access, neurovascular active devices, and core medical materials, plus OEM/CDMO manufacturing of implantable devices. Its products are registered in China, the US, the EU, Japan and South Korea, backed by nearly 100 device registrations and over 300 invention patents.

Series C · 2026-09

Pangce Medical (磅策医疗), founded in Shanghai, China in 2019, is a developer of medical surgical robots focused on core technologies including orthopedic and surgical robots and navigation positioning. The current funding round will be used for core technology iteration, new product pipeline R&D and clinical registration, commercialization channel expansion, and global market development.

Series B · $15M · 2026-04

Hilo, founded in 2018 in Switzerland, develops wearable devices for continuous cuffless blood pressure monitoring, with models trained on optical signals and readings from over 120,000 users.

Series B · $61M · 2026-07

CMR Surgical, founded in 2014 in Cambridge, UK, sells robotic surgical systems to hospitals to assist surgeons in performing procedures for cancer and bowel disease treatment.

Undisclosed · $165M · 2023-09

Nami Surgical, founded in 2021 in Glasgow, Scotland, develops miniaturized ultrasonic medical devices for surgical applications, including high-performance compact ultrasonic scalpels designed to overcome limitations in robot-assisted surgery.

Undisclosed · $4M · 2024-05

UltraSight, founded in 2018 as a joint venture of the Weizmann Institute of Science and NYU Grossman School of Medicine (formerly OnSight Medical), builds Echosystem, an FDA 510(k)-cleared AI-guided cardiac ultrasound workflow platform that lets non-specialist clinicians perform diagnostic-quality bedside echocardiography under physician oversight. It is deployed across more than 10 U.S. commercial ICU sites.

Series B · $42M · 2026-09

Combines handheld medical devices with AI software to help doctors examine patients remotely

Undisclosed · 2026-07

Nuclivision, founded in 2022 in Ghent, Belgium, develops AI software to enhance PET scan performance, enabling faster, lower-radiation imaging while maintaining diagnostic accuracy.

Undisclosed · $6M · 2025-04